(Q42279923)

19 October 2017

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer (English)

1 reference

19 October 2017

1 reference

Schneider J

1

1 reference

19 October 2017

Presek P

2

1 reference

19 October 2017

Braun A

3

1 reference

19 October 2017

Bauer P

4

1 reference

19 October 2017

Konietzko N

5

1 reference

19 October 2017

Wiesner B

6

1 reference

19 October 2017

Woitowitz HJ

7

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

British Journal of Cancer

19 October 2017

1 reference

19 October 2017

80

1 reference

19 October 2017

12

1 reference

19 October 2017

1987-1994

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690632

19 October 2017

0 references

cites work

p53 protein is absent from the serum of patients with lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

The c-erbB transmembrane growth factor receptors as serum biomarkers in human cancer studies

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Clinical implications of the p53 tumor-suppressor gene

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Immunohistochemical study of p53 in human lung carcinomas.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

The relationship between serum p53 autoantibodies and characteristics of human breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Detection of serum p53 protein in lung cancer patients

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Epidermal growth factor in breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Biochemical and molecular epidemiology of cancer.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Application of molecular genetics to the early diagnosis and screening of lung cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Immunohistochemical evaluation of E-cadherin and epidermal growth factor receptor in non-small cell lung cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Elevated serum levels of pantropic p53 proteins in chromium workers.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363153

Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer

17 August 2018

1 reference

12 December 2020

Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation

1 reference

12 December 2020

Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure

1 reference

12 December 2020

Epidermal growth factor receptor expression in human lung cancer cell lines

1 reference

12 December 2020

Epidermal growth factor receptor in adenocarcinoma of the kidney

1 reference

12 December 2020

Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients

1 reference

12 December 2020

Serum oncoproteins and growth factors in asbestosis and silicosis patients

1 reference

12 December 2020

Serum Neopterin After Lung Transplantation

1 reference

12 December 2020

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung

1 reference

12 December 2020

Evidence for a role of EGF receptor in the progression of human lung carcinoma

1 reference

12 December 2020

p53 mutation hotspot in radon-associated lung cancer

1 reference

12 December 2020

The p53 tumor suppressor gene. A preliminary clinical study in breast cancer patients

1 reference

12 December 2020

Evaluation of oncogene-related proteins in serum

1 reference

12 December 2020

Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation

1 reference

12 December 2020

Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease

1 reference

12 December 2020

p53 protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke

1 reference

12 December 2020

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

1 reference

12 December 2020

Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia

1 reference

12 December 2020

Antibody response to adenovirus E1b-derived synthetic peptides and serum levels of p53 in patients with gastrointestinal and other malignant lymphomas

1 reference

12 December 2020

p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue

1 reference

12 December 2020

Serum p53 antibodies as early markers of lung cancer

1 reference

12 December 2020

The molecular biology of lung cancer pathogenesis

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690632

7 January 2021

inferred from DOI database lookup

Prognostic factors in NSCLC. Recent experiences

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690632

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJC.6690632

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

10471051

1 reference